(E)-5-hydroxy-2-(3-hydroxybenzylidene)-3,4-dihydronaphthalen-1(2H)-one

ID: ALA4535634

Chembl Id: CHEMBL4535634

PubChem CID: 155548049

Max Phase: Preclinical

Molecular Formula: C17H14O3

Molecular Weight: 266.30

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1/C(=C/c2cccc(O)c2)CCc2c(O)cccc21

Standard InChI:  InChI=1S/C17H14O3/c18-13-4-1-3-11(10-13)9-12-7-8-14-15(17(12)20)5-2-6-16(14)19/h1-6,9-10,18-19H,7-8H2/b12-9+

Standard InChI Key:  QUVXBPVTGLXVTR-FMIVXFBMSA-N

Alternative Forms

  1. Parent:

    ALA4535634

    ---

Associated Targets(non-human)

Adora1 Adenosine A1 receptor (6163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora2a Adenosine A2a receptor (3360 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Adrenergic receptor alpha-1 (5652 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra2a Alpha-2a adrenergic receptor (204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 266.30Molecular Weight (Monoisotopic): 266.0943AlogP: 3.31#Rotatable Bonds: 1
Polar Surface Area: 57.53Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.01CX Basic pKa: CX LogP: 3.73CX LogD: 3.72
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.78Np Likeness Score: 0.47

References

1. Janse van Rensburg HD, Legoabe LJ, Terre'Blanche G, Van der Walt MM..  (2019)  Methoxy substituted 2-benzylidene-1-indanone derivatives as A1 and/or A2A AR antagonists for the potential treatment of neurological conditions.,  10  (2): [PMID:30881617] [10.1039/C8MD00540K]
2. Kunwar S, Min Lee S, Man Kadayat T, Shrestha A, Park PH, Lee ES..  (2022)  Potent inhibitory activity of hydroxylated 2-benzylidene-3,4-dihydronaphthalen-1(2H)-ones on LPS-stimulated reactive oxygen species production in RAW 264.7 macrophages.,  73  [PMID:35932905] [10.1016/j.bmcl.2022.128921]
3. Sheng K, Song Y, Lei F, Zhao W, Fan L, Wu L, Liu Y, Wu S, Zhang Y..  (2022)  Research progress in pharmacological activities and structure-activity relationships of tetralone scaffolds as pharmacophore and fluorescent skeleton.,  227  [PMID:34743062] [10.1016/j.ejmech.2021.113964]

Source